ML Pharma

Brussel ·KBO/BCE: BE 0795.627.454

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	17.0%	17.5%	better than 49% of 858 sector peers
Net result	€67k	€14k	better than 70% of 859 sector peers
Equity	€109k	€101k	better than 52% of 860 sector peers
Gross operating margin	€240k	€213k	better than 53% of 787 sector peers
Staff costs	€90k	€219k	higher than 26% of 708 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€643k
Fixed assets	21/28	€317k
Intangible fixed assets	21	€208k
Tangible fixed assets	22/27	€109k
Current assets	29/58	€326k
Stocks & contracts in progress	3	€83k
Amounts receivable within one year	40/41	€104k
Cash & bank	54/58	€135k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€643k
Equity	10/15	€109k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€99k
Amounts payable	17/49	€534k
Amounts payable after one year	17	€200k
Amounts payable within one year	42/48	€332k
Trade debts payable within one year	44	€141k
Income statement
Gross operating margin	9900	€240k
Operating result	9901	€108k
Financial charges	65	€16k
Result before taxes	9903	€92k
Income taxes	67/77	€25k
Net result for the period	9904	€67k
Result to be appropriated	9905	€67k

Summary